AML3D (ASX:AL3) wins a ~A$2.2m ARCEMY X order from Northrop Grumman, its first US Navy prime customer win in a growing ...

Metallium (ASX:MTM) signs a non-binding MOU with US$10bn commodity trader Traxys to commercialise its US critical metals ...

Pureprofile (ASX:PPL) posted record Q1 FY27 revenue of A$18.3m as Platform revenue doubled and EBITDA margin expanded to 13%.

Cochlear (ASX:COH) reaffirmed FY27 profit guidance of $330m to $350m at today's AGM after a soft FY26 and a reset of the ...

Genmab (NDQ:GMAB) enters FY26 as one of the most profitable royalty engines in global oncology. The company’s antibody ...

United Therapeutics (NDQ:UNTR) is the only listed company attempting to industrialise the supply of transplantable organs.

Why could the US stock market fall this week? PCE inflation and GDP data could shake the S&P 500 and Nasdaq. Here's what ...

Tuas (ASX:TUA) plunged after Singapore's IMDA escalated its Simba probe, raising the risk of spectrum restrictions, fines and licence action.

Palo Alto Networks shares gained approximately 7.2% on October 23, closing at US$380.31 as cybersecurity stocks rallied. Evercore ISI's latest channel survey indicated strengthening cybersecurity ...

Temple & Webster (ASX:TPW) guided FY27 EBITDA to A$33-40m at its AGM, up 50-80%, as margin discipline and private label ...

Tempus AI (NDQ:TEM) is another one of those early-stage NASDAQ biotechs hoping to go from the tens of billions into the hundreds of billions in market ...

Hawk Resources (ASX:HWK) lab assays at Olympus returned 11ppm scandium against historical pXRF readings of 742ppm, raising ...